EMBC241220C5000
- 0.00
- 0.000.00%
Embecta Newsroom
Embecta | 10-K: FY2024 Annual Report
BTIG Maintains Embecta(EMBC.US) With Buy Rating, Maintains Target Price $26
BTIG Upgrades Embecta Corporation (EMBC) to a Buy
Embecta To Go Ex-Dividend On December 6th, 2024 With 0.15 USD Dividend Per Share
December 4th (Eastern Time) - $Embecta(EMBC.US)$ is trading ex-dividend on December 6th, 2024.Shareholders of record on December 6th, 2024 will receive 0.15 USD dividend per share on December 18th, 20
Embecta Corp Appoints Anthony Roth as VP and CAO
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley Upgrades Embecta to Equalweight, Price Target Is $20
Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Embecta Raised to Buy From Neutral by BTIG
Embecta Price Target Announced at $26.00/Share by BTIG
Embecta Analyst Ratings
BTIG Upgrades Embecta(EMBC.US) to Buy Rating, Announces Target Price $26
Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13
Embecta Corporation: Discontinued Patch Pump Program and Financial Shortfalls Prompt Sell Rating
Embecta Corporation's Strategic Shifts and Revenue Outlook Prompt 'Sell' Rating
Market Might Still Lack Some Conviction On Embecta Corp. (NASDAQ:EMBC) Even After 35% Share Price Boost
Biggest Stock Movers Wednesday: ADSK, HPQ, URBN, EMBC, AMBA, IREN, and More
Embecta Corporation Reports Strong 2024 Financial Results